Pharmacodynamic and Pharmacokinetic Interaction Completed Phase 1 Trials for Darexaban (DB12289)

IndicationStatusPhase
DBCOND0054289 (Pharmacodynamic and Pharmacokinetic Interaction)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01424332To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects